State-dependent potentials for the $^1\text{S}_{0}$ and $^3\text{P}_{0}$ clock states of neutral ytterbium atoms
Authors:
Tim O. Höhn,
Etienne Staub,
Guillaume Brochier,
Nelson Darkwah Oppong,
Monika Aidelsburger
Abstract:
We present measurements of three distinctive state-(in)dependent wavelengths for the $^1\text{S}_{0}-^3\text{P}_{0}$ clock transition in $^{174}\text{Yb}$ atoms. Specifically, we determine two magic wavelengths at $652.281(21)\,$THz and $542.50205(19)\,$THz, where the differential light shift on the $^1\text{S}_{0}-^3\text{P}_{0}$ clock transition vanishes, and one tune-out wavelength at…
▽ More
We present measurements of three distinctive state-(in)dependent wavelengths for the $^1\text{S}_{0}-^3\text{P}_{0}$ clock transition in $^{174}\text{Yb}$ atoms. Specifically, we determine two magic wavelengths at $652.281(21)\,$THz and $542.50205(19)\,$THz, where the differential light shift on the $^1\text{S}_{0}-^3\text{P}_{0}$ clock transition vanishes, and one tune-out wavelength at $541.8325(5)\,$THz, where the polarizability of the $^1\text{S}_{0}$ ground state exhibits a zero crossing. The two new magic wavelengths are identified by spectroscopically interrogating cold $^{174}\text{Yb}$ atoms on the clock transition in a one-dimensional optical lattice. The ground-state tune-out wavelength is determined via a parametric heating scheme. With a simple empirical model, we then extrapolate the ground and excited state polarizability over a broad range of wavelengths in the visible spectrum.
△ Less
Submitted 17 August, 2023; v1 submitted 31 May, 2023;
originally announced May 2023.
A generative recommender system with GMM prior for cancer drug generation and sensitivity prediction
Authors:
Krzysztof Koras,
Marcin Możejko,
Paulina Szymczak,
Eike Staub,
Ewa Szczurek
Abstract:
Recent emergence of high-throughput drug screening assays sparkled an intensive development of machine learning methods, including models for prediction of sensitivity of cancer cell lines to anti-cancer drugs, as well as methods for generation of potential drug candidates. However, a concept of generation of compounds with specific properties and simultaneous modeling of their efficacy against ca…
▽ More
Recent emergence of high-throughput drug screening assays sparkled an intensive development of machine learning methods, including models for prediction of sensitivity of cancer cell lines to anti-cancer drugs, as well as methods for generation of potential drug candidates. However, a concept of generation of compounds with specific properties and simultaneous modeling of their efficacy against cancer cell lines has not been comprehensively explored. To address this need, we present VADEERS, a Variational Autoencoder-based Drug Efficacy Estimation Recommender System. The generation of compounds is performed by a novel variational autoencoder with a semi-supervised Gaussian Mixture Model (GMM) prior. The prior defines a clustering in the latent space, where the clusters are associated with specific drug properties. In addition, VADEERS is equipped with a cell line autoencoder and a sensitivity prediction network. The model combines data for SMILES string representations of anti-cancer drugs, their inhibition profiles against a panel of protein kinases, cell lines biological features and measurements of the sensitivity of the cell lines to the drugs. The evaluated variants of VADEERS achieve a high r=0.87 Pearson correlation between true and predicted drug sensitivity estimates. We train the GMM prior in such a way that the clusters in the latent space correspond to a pre-computed clustering of the drugs by their inhibitory profiles. We show that the learned latent representations and new generated data points accurately reflect the given clustering. In summary, VADEERS offers a comprehensive model of drugs and cell lines properties and relationships between them, as well as a guided generation of novel compounds.
△ Less
Submitted 7 June, 2022;
originally announced June 2022.
